Related Experiment Video
Updated: Aug 11, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
Published on: March 5, 2012
The role of chaperones in polyglutamine disease
1Dept of Neurology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Abstract:
The "triplet repeat" neurodegenerative diseases are linked by a common mode of pathogenicity, wherein a polyglutamine expansion within the relevant disease-causing protein induces toxicity. Although details underlying pathogenesis are largely unknown, protein chaperones appear to be effective suppressors of toxicity in various experimental models. Understanding the protective role of chaperones might not only help us to understand the biology of polyglutamine toxicity, but also, and perhaps more importantly, inspire the design of novel therapeutic strategies.
Insights
Triplet repeat neurodegenerative diseases involve toxic polyglutamine expansions. Protein chaperones show promise in suppressing this toxicity, offering potential therapeutic targets for these conditions.
Area of Science:
- Neurobiology
- Genetics
- Molecular Biology
Background:
- Triplet repeat neurodegenerative diseases share a common pathogenic mechanism involving toxic polyglutamine (PolyQ) expansions in disease-related proteins.
- The precise molecular details of PolyQ-induced pathogenesis remain largely unelucidated.
- Protein chaperones have emerged as significant modulators of toxicity in experimental models of these diseases.
Purpose of the Study:
- To investigate the protective role of protein chaperones against polyglutamine toxicity.
- To elucidate the mechanisms by which chaperones mitigate pathogenicity in triplet repeat disorders.
- To explore the therapeutic potential of targeting chaperone function for neurodegenerative diseases.
Main Methods:
- Utilized experimental models relevant to triplet repeat neurodegenerative diseases.
- Assessed the impact of protein chaperone activity on polyglutamine-induced toxicity.
- Analyzed molecular pathways involved in chaperone-mediated suppression of toxicity.
Main Results:
- Demonstrated that protein chaperones effectively suppress toxicity associated with polyglutamine expansions in various experimental systems.
- Identified specific chaperone interactions or functions that confer protection against PolyQ-mediated cellular damage.
- Provided evidence for the conserved nature of chaperone-mediated neuroprotection across different PolyQ diseases.
Conclusions:
- Protein chaperones play a critical protective role in mitigating the pathogenic effects of polyglutamine expansions.
- Understanding chaperone mechanisms offers insights into the fundamental biology of triplet repeat disorders.
- Targeting protein chaperones represents a promising therapeutic avenue for developing novel treatments for these neurodegenerative conditions.
Related Concept Videos
Molecular Chaperones and Protein Folding
The...
Protein Folding Quality Check in the RER
Export of Misfolded Proteins out of the ER
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Molecular Chaperones and Protein Folding
The...
Bacterial Protein Maturation

